Approval · Notice of Compliance 27483 · 2022
TEVA-PROFEN: Notice of Compliance 27483
Issued January 26, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27483
- Date
- January 26, 2022
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the Product Monograph as per Health Canada¿s Advisement Letter. Update Product Monograph to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-PROFEN | Not yet assigned | — |
Medicinal ingredients
- IBUPROFEN 600 MG per TAB